PE firm InvAscent keen to list five portfolio companies

Mumbai: Private equity firm InvAscent is preparing to list five portfolio companies across health and pharmaceuticals…

Hikal appoints two independent directors amid family feud

New Delhi: Mumbai-based pharmaceutical and life sciences company Hikal Limited has appointed two experts — Berjis…

About 25-30% of products sold in India are counterfeit with fakes: Report

New Delhi : About 25-30% of all products sold in the country are counterfeit, with counterfeiting…

Why biotechs are poised for recovery this year

Pharma and biotech stocks moved in opposite directions last year, but fortunes are turning

Aurobindo Pharma’s Q2 net profit down 41% at Rs 409 crore

Shares of the pharmaceutical company closed at Rs 488 on the BSE on Friday. Hyderabad: Aurobindo…

Quadria Capital eyes Concorde Biotech

Healthcare-focused private equity fund Quadria Capital will sell its entire 20% stake in active pharmaceutical ingredients…

India wants easy access to pharma market for Australia

Two government officials said on condition of anonymity that India is pressing for preferential market access…

To back surprising USFDA oversight

The US Food and Drug Administration will soon begin unannounced inspections of drug manufacturing facilities outside…